Full-Time
Senior Product Sales Manager
Higher Education
Clarivate
10,001+ employees
Subscription analytics for research and IP
No salary listed
Company Does Not Provide H1B Sponsorship
Remote in USA
Remote
Remote within the United States, with travel up to 50% domestically. Core hours are primarily in the employee’s time zone, with flexibility for global time zones.
Bachelor's
 Sales & Account Management (2) |
|---|
| , |
Get referred to Clarivate
See people who can refer or advise you
- A bachelor's degree or equivalent relevant work experience.
- At least 7 years of experience in research platform solutions, application programming interfaces or other integration, custom data sets, reports, or a combination of these alongside consultancy services to academic clients.
- Achieve sales targets for assigned products and territories, ensuring alignment with the company’s overall business objectives.
- Identify and support new business opportunities independently and in collaboration with Account Managers to drive growth and expand market presence.
- Leverage product expertise to design and present value-added solutions that enhance deal value and address customer needs.
- Develop and maintain a robust sales pipeline with Account Managers, using effective sales and negotiation strategies to enhance deal size and accelerate sales cycles.
- Establish and nurture customer relationships through regular communication, exceptional service, and proactive problem-solving to ensure ongoing customer loyalty and satisfaction.
- Collaborate with Account Managers and other commercial teams on product sales planning and execute sales strategies that maximize the company’s footprint.
- Build and present reports covering current and proposed activities, customer interactions, pipeline status, accurate sales forecasts, and closing timelines.
- Consult with cross-functional teams to develop and implement effective sales campaigns and new business activities.
- Continuously acquire and develop relevant market, industry, and product knowledge to enhance commercial effectiveness and support sales success.
- Prior selling experience and in-depth knowledge of the United States academic market.
- Prior experience with academic bids and tenders.
- Experience in higher education.
- A proven track record of business development.
- Experience developing accounts through proactive prospecting.
- Experience conducting deep discovery to understand customer workflow and content needs.
- Ability to cultivate strong customer relationships with senior stakeholders.
- Consistent achievement of commercial targets in a complex sales environment.
Clarivate provides subscription-based analytics platforms and services focused on bibliometrics, scientometrics, business and patent intelligence, and regulatory standards for researchers, organizations, and regulators. Its products, including Web of Science and Derwent World Patents Index, give access to citation and patent data through a subscription model, enabling users to search, analyze, and generate reports. It stands out by offering an integrated suite that spans academia, intellectual property, and regulatory domains, backed by long-standing, curated data and trusted brands. The goal is to help organizations accelerate innovation and protect and manage their intellectual assets through reliable data, analytics, and regulatory intelligence.
Company Size
10,001+
Company Stage
IPO
Headquarters
London, United Kingdom
Founded
2016
Get referred to Clarivate
See people who can refer or advise you
Simplify's Take
What believers are saying
- Clarivate's Q2 2026 organic subscription revenue grew 0.7%, despite divestiture-driven headline declines.
- Management reaffirmed 2026 guidance on July 29, and free cash flow reached $122.9 million.
- Clarivate launched enhanced SkyRiver on August 12, 2026, adding open metadata and AI-assisted creation.
What critics are saying
- Revenue fell 5.5% in Q2 2026, and Life Sciences & Healthcare shrank 11.7%.
- Clarivate recorded a $221.7 million goodwill impairment and a $268.6 million Q2 net loss.
- Open bibliographic data and AI search from Google, OpenAlex, and Anthropic compress Clarivate's moat.
What makes Clarivate unique
- Clarivate's proprietary Web of Science and Derwent databases anchor sticky academic and patent workflows.
- Clarivate's August 6, 2026 Cortellis agentic AI embeds workflow execution into trusted life-sciences data.
- The July 2026 Altaris sale refocuses Clarivate on subscription-heavy Academia and Intellectual Property.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Hybrid Work Options
Flexible Work Hours
Remote Work Options
Growth & Insights and Company News
6 month growth
↑ 34%1 year growth
↑ 34%2 year growth
↑ 38%AI-Driven SaaS earnings power Tech stock upswing. SaasRise - Aug 17, 2026 AI-centric SaaS companies such as Doximity and Clarivate reported robust earnings and raised guidance, helping lift software stocks this month. The earnings beat highlights growing demand for AI-enhanced workflow tools and data-intelligence platforms. Why it matters. The strong earnings from AI-centric SaaS firms illustrate a shift in the software market: AI is no longer a peripheral add-on but a core growth engine. High net-revenue retention and accelerated bookings indicate that customers are willing to pay premium prices for AI-enhanced productivity, creating defensible revenue streams and higher expansion rates. For investors, these results validate higher multiples for AI-native SaaS companies, while for operators they highlight the strategic imperative to embed AI deeply into product and GTM strategies. Moreover, the rebound in software equities suggests that the market is re-pricing risk around AI adoption. Companies that can demonstrate measurable AI-driven ROI are likely to capture a larger share of the growing enterprise spend on automation and data intelligence, reinforcing competitive moats and fueling further valuation upside. Key points. * Doximity Q1 revenue $156.6M (+7% YoY) and raised FY2027 guidance to $671-$681M * Clarivate Q2 revenue $257.5M (+6.6% YoY) with bookings $30M ACV, 150% YoY growth * Both firms reported net-revenue retention above 100%, indicating strong expansion revenue * AI-driven product launches (Doximity AI search, Clarivate claims-intelligence) are central to growth * Tech market sentiment turned positive, with Nasdaq 100 futures up 0.2% and S&P 500 hitting fresh highs Analysis. The earnings surge from Doximity and Clarivate marks a inflection point for AI-enabled SaaS. Historically, AI has been a differentiator for a subset of high-growth software firms, but the current wave shows it becoming a baseline expectation for enterprise productivity tools. This shift mirrors the early 2010s transition when cloud infrastructure moved from a cost-center to a strategic asset; today, AI is the new strategic layer that drives both top-line expansion and pricing power. From a competitive dynamics perspective, firms that have built AI into the core of their platforms - rather than bolting it on - are achieving higher gross margins and NRR, as seen with Doximity's 87.5% non-GAAP gross margin and Clarivate's 60.5% adjusted EBITDA margin. This suggests that AI-native architectures enable more efficient scaling of compute resources and better data capture, which in turn fuels cross-sell and upsell opportunities. Companies still relying on legacy SaaS models without AI integration may find themselves pressured on pricing and churn. Looking forward, the market will likely reward firms that can demonstrate concrete AI ROI, such as reduced time-to-insight or measurable cost savings for customers. As AI compute costs normalize, the margin upside could be significant, especially for platforms that can monetize AI as a separate subscription tier. Investors should watch for guidance on AI-specific ARR and the pace of AI-driven expansion revenue, while operators must prioritize data hygiene, model governance, and seamless UX to sustain the current momentum.
Clarivate opens up library metadata with enhanced SkyRiver. 12 August 2026 Clarivate has launched an enhanced version of its SkyRiver platform, with a focus on open bibliographic metadata, interoperability and AI-assisted record creation for libraries. The company said the updated platform is designed to give libraries a more affordable way to source, manage and share bibliographic metadata across institutions, consortia and different library management systems. SkyRiver uses open metadata by default, with records intended to be as reusable as possible while still respecting contributor requirements, licensing obligations and institutional governance policies. Libraries retain control over whether and how they participate and contribute metadata. The launch comes as libraries face growing pressure to improve efficiency while adapting their discovery services. Clarivate argues that trusted and interoperable metadata will become increasingly important to those services, particularly as artificial intelligence plays a greater role in discovery and cataloguing. The enhanced SkyRiver platform includes AI-powered record creation capabilities intended to make the creation of high-quality metadata more efficient. Yoel Goldenberg, Senior Vice President, Product Management, Academia & Government at Clarivate, said: "Libraries need trusted metadata that can be shared, reused and integrated across systems without sacrificing choice, transparency or governance. "The enhanced SkyRiver platform helps libraries work more efficiently through community open metadata sharing, while introducing AI-powered capabilities that make it easier to create high-quality records. As libraries explore the future of discovery, trusted metadata will be more important than ever." Clarivate said the platform is intended to enable libraries to exchange and reuse metadata across different library management systems and improve interoperability between individual institutions, consortia and wider library networks. Users will also have access to information about the rights, sources, attribution and access conditions associated with metadata. The approach is intended to allow institutions to reuse open bibliographic metadata while retaining local control and respecting contributor and licensing requirements. Trevor A. Dawes, Vice Provost for Libraries and Museums and May Morris University Librarian, University of Delaware, said: "Our partnership with Clarivate on SkyRiver reflects our commitment to high-quality, open metadata that increases the visibility and discoverability of our collections while supporting collaboration across the library community." Brett Waytuck, Dean, University Libraries and Archives, University of Regina, said: "Discoverability depends on trusted metadata and workflows that recognise the value libraries contribute. The enhanced SkyRiver platform presents an opportunity to explore a practical approach that preserves local metadata enhancements, integrates with existing operations and helps libraries realise greater value from their collections." Alongside the platform launch, Clarivate plans to establish a Metadata Governance Advisory Group. The group will provide community input into the future development of SkyRiver, including its metadata policies, quality standards and governance principles. Clarivate said the initiative forms part of a wider commitment to transparency and community engagement around the development and use of bibliographic metadata.
Clarivate has expanded agentic AI capabilities across its Cortellis portfolio to help life sciences organisations accelerate drug development. The enhanced platform integrates AI into existing workflows, enabling research and development teams to reduce manual work and make faster decisions throughout the drug development lifecycle. The Cortellis suite combines life sciences data, expert curation, and AI to support R&D, portfolio strategy, business development, and regulatory professionals. The latest AI features aim to speed up work across discovery, safety assessment, and portfolio strategy. Anne Lecocq, senior vice president and general manager for R&D at Clarivate, said the platform has evolved from delivering insights to executing workflows across the product lifecycle. The system is built on proprietary data and embedded AI to help teams connect evidence and streamline complex processes.
Clarivate reported Q2 revenue of $587.3 million, down 5.5% year-over-year, slightly beating the consensus estimate of $587.06 million. The company posted earnings per share of $0.19, up from $0.18 a year ago and surpassing analyst expectations of $0.17. By segment, Life Sciences & Healthcare revenue fell 11.7% to $88.7 million, missing estimates of $93.25 million. Academia & Government revenue declined 5.7% to $300.3 million, exceeding the $294.8 million estimate. Intellectual Property revenue dropped 2.1% to $198.3 million, above the projected $197.2 million. Clarivate shares have risen 11.1% over the past month, outperforming the S&P 500's 1.9% gain. The stock currently holds a Zacks Rank 3 rating.
Clarivate (NYSE:CLVT) Price Target lowered to $2.50 at Citigroup. July 30, 2026 Key points. * Citigroup lowered Clarivate's price target to $2.50 from $2.80 while maintaining a neutral rating, implying roughly 25% upside from the prior close. * Analyst sentiment remains cautious: Clarivate has an average "Reduce" rating and a consensus price target of $3.02, with recent target cuts from Stifel, Goldman Sachs, and Barclays. * Clarivate narrowly beat quarterly EPS expectations at $0.19, but revenue fell 5.5% year over year to $587.3 million and missed estimates, while the company continued to report a negative net margin. * Interested in Clarivate? Here are five stocks we like better. Clarivate (NYSE:CLVT - Get Free Report) had its target price decreased by equities research analysts at Citigroup from $2.80 to $2.50 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a "neutral" rating on the stock. Citigroup's target price points to a potential upside of 25.31% from the company's previous close. Several other equities research analysts have also recently issued reports on CLVT. Stifel Nicolaus cut their price target on Clarivate from $6.00 to $5.00 and set a "buy" rating for the company in a research note on Thursday. Wall Street Zen raised Clarivate from a "hold" rating to a "buy" rating in a report on Saturday, May 2nd. The Goldman Sachs Group cut their target price on Clarivate from $2.90 to $2.60 and set a "neutral" rating for the company in a research report on Thursday. Weiss Ratings reissued a "sell (e+)" rating on shares of Clarivate in a report on Wednesday, June 24th. Finally, Barclays dropped their price target on Clarivate from $2.50 to $2.00 and set an "underweight" rating for the company in a research note on Thursday. One equities research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, Clarivate currently has an average rating of "Reduce" and an average target price of $3.02. Clarivate stock performance. Clarivate stock traded down $0.15 during midday trading on Thursday, hitting $2.00. The company's stock had a trading volume of 4,179,151 shares, compared to its average volume of 6,810,947. Clarivate has a 1-year low of $1.66 and a 1-year high of $4.55. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.84 and a quick ratio of 0.84. The company has a 50-day moving average price of $2.29 and a two-hundred day moving average price of $2.43. The company has a market cap of $1.28 billion, a price-to-earnings ratio of -9.55 and a beta of 1.38. Clarivate (NYSE:CLVT - Get Free Report) last announced its earnings results on Wednesday, July 29th. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.18 by $0.01. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. The firm had revenue of $587.30 million for the quarter, compared to analyst estimates of $589.73 million. During the same quarter in the prior year, the business posted $0.18 EPS. The business's revenue was down 5.5% compared to the same quarter last year. As a group, sell-side analysts predict that Clarivate will post 0.65 earnings per share for the current year. Hedge funds weigh in on Clarivate. A number of hedge funds have recently bought and sold shares of CLVT. Iridian Asset Management LLC CT raised its position in shares of Clarivate by 52.4% in the 4th quarter. Iridian Asset Management LLC CT now owns 1,528,410 shares of the company's stock worth $5,105,000 after acquiring an additional 525,452 shares in the last quarter. KBC Group NV acquired a new position in shares of Clarivate in the 1st quarter valued at about $4,118,000. BW Gestao de Investimentos Ltda. boosted its position in shares of Clarivate by 51.7% during the 4th quarter. BW Gestao de Investimentos Ltda. now owns 4,345,321 shares of the company's stock valued at $14,513,000 after purchasing an additional 1,480,300 shares in the last quarter. LSV Asset Management boosted its position in shares of Clarivate by 25.6% during the 4th quarter. LSV Asset Management now owns 2,647,900 shares of the company's stock valued at $8,844,000 after purchasing an additional 540,400 shares in the last quarter. Finally, Invenomic Capital Management LP grew its stake in Clarivate by 3.8% during the fourth quarter. Invenomic Capital Management LP now owns 9,029,414 shares of the company's stock worth $30,158,000 after purchasing an additional 326,369 shares during the period. Institutional investors own 85.72% of the company's stock. Clarivate news roundup. Here are the key news stories impacting Clarivate this week: * Positive Sentiment: Adjusted earnings exceeded expectations. Clarivate reported second-quarter EPS of $0.19, above the $0.17-$0.18 analyst consensus and up from $0.18 a year earlier. Clarivate Reports Second Quarter 2026 Results * Positive Sentiment: Management reaffirmed its 2026 financial outlook and said its Value Creation Plan is advancing strategic priorities, improving the company's financial profile and supporting a sharper focus following the planned Life Sciences & Healthcare divestiture. Clarivate Reports Second Quarter 2026 Results * Positive Sentiment: Stifel Nicolaus maintained a Buy rating and sees substantial potential upside, although it reduced its price target from $6 to $5. Clarivate Price Target Update * Neutral Sentiment: Clarivate appointed Michael Easton as executive vice president and CFO, effective August 8. Easton, a longtime company executive with more than 25 years of financial and operational experience, will replace Jonathan Collins, who is leaving to pursue another opportunity. Clarivate Appoints Michael Easton as Chief Financial Officer * Negative Sentiment: Revenue was weaker than expected and declined year over year. Quarterly revenue of $587.3 million missed the approximately $589.7 million consensus estimate and fell 5.5% from the prior-year period. Clarivate also reported a negative net margin, underscoring ongoing concerns about growth and profitability. Clarivate Q2 Earnings and Revenues * Negative Sentiment: The lower Stifel price target signals reduced near-term expectations despite the continued Buy rating, adding pressure to the investment case. About Clarivate. Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms. Originally part of Thomson Reuters' Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Clarivate, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list. While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys. The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.